育龄女性避孕方式特异性抗苗勒管激素值:42684名女性的人群研究
该研究为前瞻性招募队列的横断面分析,纳入2018年5月至2021年11月购买生育激素检测并同意研究的美国育龄女性,比较不同避孕方式使用者的年龄及避孕方式特异性AMH水平。结果显示复方口服避孕药使用者AMH降低17%(效应估计0.83,95%CI 0.82-0.85),而激素宫内节育器无影响(1.00,95%CI 0.98-1.03),抑制效应在低AMH百分位最大、高百分位最小,但避孕方式依赖的差异相对于已知的卵巢储备生物学变异较小。
要点
- 复方口服避孕药使用者AMH降低17%(效应估计0.83,95%CI 0.82-0.85),激素宫内节育器无影响(1.00,95%CI 0.98-1.03)。
- 避孕方式对AMH的抑制效应在低百分位最大、高百分位最小,如复方口服避孕药第10百分位降低32%、第90百分位降低5%。
- 未观察到年龄特异性抑制差异,且避孕方式依赖的差异相对于已知卵巢储备生物学变异较小。
核心结论
- 激素避孕药对AMH水平的影响因避孕方式而异,且效应在低AMH百分位最大,但这些差异相对于任何给定年龄的已知卵巢储备生物学变异较小。
- 这些参考值可在不要求停用或取出避孕措施的情况下,稳健评估个体相对于同龄人的卵巢储备。
研究设计与样本
- 前瞻性招募队列的横断面分析,设置于社区。
- 纳入2018年5月至2021年11月购买生育激素检测并同意研究的美国育龄女性。
- 参与者为各种避孕方式使用者:复方口服避孕药(n=6850)、孕激素-only药片(n=465)、激素宫内节育器(n=4867)或铜宫内节育器(n=1268)、皮下埋植(n=834)、阴道环(n=886),以及月经周期规律的女性(n=27514)。
主要发现
- 避孕方式对AMH存在特异性效应,效应估计从复方口服避孕药的0.83(95%CI 0.82-0.85,降低17%)到激素宫内节育器的无效应(1.00,95%CI 0.98-1.03)。
- 未观察到年龄特异性抑制差异。
- 避孕方式对AMH的抑制效应在不同AMH百分位存在差异,低百分位效应最大、高百分位效应最小。
- 以复方口服避孕药为例,第10百分位AMH降低32%(系数0.68,95%CI 0.65-0.71),第50百分位降低19%(系数0.81,95%CI 0.79-0.84),第90百分位降低5%(系数0.95,95%CI 0.92-0.98),其他避孕方式显示类似的不一致。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine how the contraceptive-specific serum antimüllerian hormone (AMH) levels compare across ages and percentiles in a reproductive-age cohort. DESIGN: Cross-sectional analysis of a prospectively recruited cohort. SETTING: Community. PATIENT(S): This study included US-based women of reproductive age who purchased a fertility hormone test and consented to participate in research between May 2018 and November 2021. At the time of hormone testing, participants were users of various contraceptives (combined oral contraceptive [n = 6,850], progestin-only pill [n = 465], hormonal [n = 4,867] or copper [n = 1,268] intrauterine device, implant [n = 834], vaginal ring [n = 886]) or women with regular menstrual cycles (n = 27,514). INTERVENTION(S): Contraceptive use. MAIN OUTCOME MEASURE(S): Age and contraceptive-specific estimates of AMH. RESULT(S): There were contraceptive-specific effects on AMH with effect estimates ranging from 0.83 (95% confidence interval [CI], 0.82-0.85) (17% lower) for the combined oral contraceptive pill to no effect (1.00; 95% CI, 0.98-1.03) for the hormonal intrauterine device. We did not observe age-specific differences in suppression. However, there were differential suppressive effects of the contraceptive method across AMH percentiles, with the greatest effect at lower percentiles and least effect at higher percentiles. For example, for women taking the combined oral contraceptive pill, the AMH level was 32% lower at the 10th percentile (coefficient, 0.68; 95% CI, 0.65-0.71), 19% lower at the 50th percentile (coefficient, 0.81; 95% CI, 0.79-0.84), and 5% lower at the 90th percentile (coefficient, 0.95; 95% CI, 0.92-0.98), with other forms of contraception showing similar discordances. CONCLUSION(S): These findings reinforce the body of literature that shows that hormonal contraceptives have different impacts on the AMH levels at a population level. These results add to this literature that these effects are not consistent; instead, the greatest impact occurs at the lower AMH percentiles. However, these contraceptive-dependent differences are small compared with the known biological variability in ovarian reserve at any given age. These reference values enable robust assessment of an individual's ovarian reserve relative to their peers without requiring cessation or potentially invasive removal of contraception.
引用
- Nelson SM, Ewing BJ, Gromski PS, et al. Contraceptive-specific antimüllerian hormone values in reproductive-age women: a population study of 42,684 women. Fertil Steril. 2023. PMID: 36801456. doi:10.1016/j.fertnstert.2023.02.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。